Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

By Christy Santhosh and Kamal Choudhury (Reuters) -Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into ...

Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services (HHS) secretary, sat through his second Senate ...

SAN ANTONIO - The attorney for a young woman on trial for the brutal murder of her own grandmother is asking the judge to find her not guilty by reason of insan ...